PhaseBio to Present at Needham & Company’s 16th Annual Healthcare Conference
MALVERN, Pa., March 29, 2017 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing biopolymer-based drugs for the treatment of orphan diseases with an initial focus on cardiopulmonary disorders, today …